Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2
Salwa Naushin, Viren Sardana, Rajat Ujjainiya, Nitin Bhatheja, Rintu Kutum, Akash Kumar Bhaskar, Shalini Pradhan, Satyartha Prakash, Raju Khan, Birendra Singh Rawat, Karthik Bharadwaj Tallapaka, Mahesh Anumalla, Giriraj Ratan Chandak, Amit Lahiri, Susanta Kar, Shrikant Ramesh Mulay, Madhav Nilakanth Mugale, Mrigank Srivastava, Shaziya Khan, Anjali Srivastava, Bhawana Tomar, Murugan Veerapandian, Ganesh Venkatachalam, Selvamani Raja Vijayakumar, Ajay Agarwal, Dinesh Gupta, Prakash M Halami, Muthukumar Serva Peddha, Gopinath M Sundaram, Ravindra P Veeranna, Anirban Pal, Vinay Kumar Agarwal, Anil Ku Maurya, Ranvijay Kumar Singh, Ashok Kumar Raman, Suresh Kumar Anandasadagopan, Parimala Karuppanan, Subramanian Venkatesan, Harish Kumar Sardana, Anamika Kothari, Rishabh Jain, Anupama Thakur, Devendra Singh Parihar, Anas Saifi, Jasleen Kaur, Virendra Kumar, Avinash Mishra, Iranna Gogeri, Geethavani Rayasam, Praveen Singh, Rahul Chakraborty, Gaura Chaturvedi, Pinreddy Karunakar, Rohit Yadav, Sunanda Singhmar, Dayanidhi Singh, Sharmistha Sarkar, Purbasha Bhattacharya, Sundaram Acharya, Vandana Singh, Shweta Verma, Drishti Soni, Surabhi Seth, Sakshi Vashisht, Sarita Thakran, Firdaus Fatima, Akash Pratap Singh, Akanksha Sharma, Babita Sharma, Manikandan Subramanian, Yogendra S Padwad, Vipin Hallan, Vikram Patial, Damanpreet Singh, Narendra Vijay Tripude, Partha Chakrabarti, Sujay Krishna Maity, Dipyaman Ganguly, Jit Sarkar, Sistla Ramakrishna, Balthu Narender Kumar, Kiran A Kumar, Sumit G Gandhi, Piyush Singh Jamwal, Rekha Chouhan, Vijay Lakshmi Jamwal, Nitika Kapoor, Debashish Ghosh, Ghanshyam Thakkar, Umakanta Subudhi, Pradip Sen, Saumya Ray Chaudhury, Rashmi Kumar, Pawan Gupta, Amit Tuli, Deepak Sharma, Rajesh P Ringe, Mahesh Kulkarni, Dhansekaran Shanmugam, Mahesh S Dharne, Sayed G Dastager, Rakesh Joshi, Amita P Patil, Sachin N Mahajan, Abujunaid Habib Khan, Vasudev Wagh, Rakesh Kumar Yadav, Ajinkya Khilari, Mayuri Bhadange, Arvindkumar H Chaurasiya, Shabda E Kulsange, Krishna Khairnar, Shilpa Paranjape, Jatin Kalita, Narahari G Sastry, Tridip Phukan, Prasenjit Manna, Wahengbam Romi, Pankaj Bharali, Dibyajyoti Ozah, Ravi Kumar Sahu, Elapavalooru Vssk Babu, Rajeev Sukumaran, Aiswarya R Nair, Prajeesh Kooloth Valappil, Anoop Puthiyamadam, Adarsh Velayudhanpillai, Kalpana Chodankar, Samir Damare, Yennapu Madhavi, Ved Varun Aggarwal, Sumit Dahiya, Anurag Agrawal, Debasis Dash, Shantanu Sengupta
eLife, doi:10.7554/elife.66537
To understand the spread of SARS-CoV2, in August and September 2020, the Council of Scientific and Industrial Research (India) conducted a serosurvey across its constituent laboratories and centers across India. Of 10,427 volunteers, 1058 (10.14%) tested positive for SARS-CoV2 anti-nucleocapsid (anti-NC) antibodies, 95% of which had surrogate neutralization activity. Three-fourth of these recalled no symptoms. Repeat serology tests at 3 (n = 607) and 6 (n = 175) months showed stable anti-NC antibodies but declining neutralization activity. Local seropositivity was higher in densely populated cities and was inversely correlated with a 30-day change in regional test positivity rates (TPRs). Regional seropositivity above 10% was associated with declining TPR. Personal factors associated with higher odds of seropositivity were highexposure work (odds ratio,
Additional files
Supplementary files . Supplementary file 1. Male:female distribution among asymptomatic and symptomatic seropositive individuals. . Supplementary file 2. Frequency of symptoms in symptomatic seropositive individuals. . Supplementary file 3. Distribution for blood group type in our cohort against national average and positivity among different blood groups. OR: odds ratio. . Transparent reporting form
References
Agrawal, Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Writing -original draft, Project administration, Writing -review and editing; Debasis Dash, Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Writing -original draft, Project administration, Writing -review and editing; Shantanu Sengupta, Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing -original draft, Project administration, Writing -review and editing Author ORCIDs Viren Sardana
Babu, Sundaresan, Athreya, The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: results from a statewide survey in Karnataka,
doi:10.1101/2020.12.04.20243949Brown, Walensky, Serosurveillance and the COVID-19 epidemic in the US: undetected, uncertain, and out of control, Jama,
doi:10.1001/jama.2020.14017Chakrabarti, None
Conte, Toraldo, Targeting the gut-lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection, Therapeutic Advances in Respiratory Disease,
doi:10.1177/1753466620937170Dash, None
Deshpande, Sapkal, Tilekar, Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients, Indian Journal of Medical Research,
doi:10.4103/ijmr.IJMR_2382_20Dhand, Khatkar, Sample Size Calculator for Estimating a Single Proportion
Ellinghaus, Degenhardt, Bujanda, Buti, Albillos et al., Genomewide association study of severe Covid-19 with respiratory failure, The New England Journal of Medicine,
doi:10.1056/NEJMoa2020283Farsalinos, Barbouni, Niaura, Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?, Internal and Emergency Medicine,
doi:10.1007/s11739-020-02355-7Figueiredo-Campos, Blankenhaus, Mota, Gomes, Serrano et al., Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset, European Journal of Immunology,
doi:10.1002/eji.202048970Go ¨ker, Aladag ˘karakulak, Demirog ˘lu, Ceylan, ¸m et al., The effects of blood group types on the risk of COVID-19 infection and its clinical outcome, Turkish Journal of Medical Sciences,
doi:10.3906/sag-2005-395Golinelli, Boetto, Maietti, Fantini, The association between ABO blood group and SARS-CoV-2 infection: a meta-analysis, PLOS ONE,
doi:10.1371/journal.pone.0239508Jayawardena, Sooriyaarachchi, Chourdakis, Jeewandara, Ranasinghe, Enhancing immunity in viral infections, with special emphasis on COVID-19: a review, Diabetes & Metabolic Syndrome,
doi:10.1016/j.dsx.2020.04.015Khilari, None
Kru ¨ttgen, Cornelissen, Dreher, Hornef, Imo ¨hl et al., Determination of SARS-CoV-2 antibodies with assays from diasorin, Roche and IDvet, Journal of Virological Methods,
doi:10.1016/j.jviromet.2020.113978Kulkarni, None
Kumar, Visualization, Writing -review and editing
Mahesh S Dharne, None
Miyara, Vale ´rie, Morelot-Panzini, Low Rate of Daily Active Tobacco Smoking in Patients with Symptomatic COVID-19: Qeios
Mohan, Lando, Panneer, Assessment of tobacco consumption and control in India, Indian Journal of Clinical Medicine,
doi:10.1177/1179916118759289Murhekar, Bhatnagar, Selvaraju, Rade, Saravanakumar et al., Prevalence of SARS-CoV-2 infection in India: findings from the national serosurvey, May-June 2020, Indian Journal of Medical Research,
doi:10.4103/ijmr.IJMR_3290_20Murhekar, Bhatnagar, Selvaraju, Saravanakumar, Thangaraj et al., SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey, The Lancet Global Health,
doi:10.1016/S2214-109X(20)30544-1Nishiura, Kobayashi, Miyama, Suzuki, Jung et al., Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19), International Journal of Infectious Diseases,
doi:10.1016/j.ijid.2020.03.020Oran, Topol, Prevalence of asymptomatic SARS-CoV-2 infection : a narrative review, Annals of Internal Medicine,
doi:10.7326/M20-3012Ortolan, Lorenzin, Felicetti, Ramonda, Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis, International Journal of Infectious Diseases,
doi:10.1016/j.ijid.2020.07.076Padhi, Suvankar, Dash, Panda, Pati et al., ABO blood group system is associated with COVID-19 mortality: an epidemiological investigation in the indian population, Transfusion Clinique Et Biologique,
doi:10.1016/j.tracli.2020.08.009Patidar, Dhiman, Distribution of ABO and rh (D) Blood groups in India: a systematic review, ISBT Science Series,
doi:10.1111/voxs.12576Petrilli, Jones, Yang, Rajagopalan, Donnell et al., Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York city: prospective cohort study, BMJ,
doi:10.1136/bmj.m1966Rossato, Russo, Mazzocut, Vincenzo, Fioretto et al., Current smoking is not associated with COVID-19, European Respiratory Journal,
doi:10.1183/13993003.01290-2020Satpati, Sarangi, Gantait, Sero-surveillance (IgG) of SARS-CoV-2 among asymptomatic general population of paschim medinipur,
doi:10.1101/2020.09.12.20193219Sengupta, None
Seow, Graham, Merrick, Acors, Pickering et al., Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans, Nature Microbiology,
doi:10.1038/s41564-020-00813-8Shalini Pradhan ; Raju Khan, Singh Rawat, Bharadwaj Tallapaka, Anumalla, Giriraj Ratan Chandak et al., Formal analysis, Investigation, Methodology, Writing -review and editing; Satyartha Prakash, Data curation, Software, Formal analysis, Visualization
Shanmugam, None
Sharma, None
Sharma, Sharma, Basu, The seroprevalence and trends of SARS-CoV-2 in Delhi, India: a repeated population-based seroepidemiological study,
doi:10.1101/2020.12.13.20248123Singh, Chakraborty, Chaturvedi, Karunakar, Yadav et al., Resources
Singh, None
Subramanian, Formal analysis, Writing -review and editing
Who, Maintenance break
Wu, Feng, Li, Yu, Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19, Clinica Chimica Acta,
doi:10.1016/j.cca.2020.06.026Yogendra S Padwad, None
